Clincosm LogoSign in Get a demo

sorafenib

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Radiotherapy, Toripalimab, Sorafenib Trial in Beijing (Radiotherapy plus Toripalimab, Sorafenib)

Recruiting
  • Radiotherapy
  • +3 more
  • Beijing, Beijing, China
    Bo Chen
Mar 6, 2021

Hepatocellular Carcinoma, Liver Tumors, Digestive System Tumors Trial in Chengdu (TACE combined with sorafenib and PD-1 mAb)

Recruiting
  • Hepatocellular Carcinoma
  • +7 more
  • TACE combined with sorafenib and PD-1 mAb
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital and Research Institute
Sep 14, 2020

Hepatocellular Carcinoma, Sorafenib, Transarterial Chemoembolization Trial in Guangzhou (TACE+sorafenib, TACE)

Unknown status
  • Hepatocellular Carcinoma
  • +2 more
  • TACE+sorafenib
  • TACE
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Sep 24, 2019

Hepatectomy, Hepatocellular Carcinoma, Sorafenib Trial in Guangzhou (hepatic resection, transcatheter hepatic arterial

Completed
  • Hepatectomy
  • +2 more
  • hepatic resection
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 9, 2018

HCC, Radiofrequency Ablation, Sorafenib Trial in Chongqing (RFA + Sorafenib, RFA)

Unknown status
  • HCC
  • +2 more
  • RFA + Sorafenib
  • RFA
  • Chongqing, Chongqing, China
    Institute of hepatobiliary surgery,southwest hospital
Mar 27, 2017